Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 96 P19 | DOI: 10.1530/endoabs.96.P19

UKINETS2023 Poster Presentations Section (27 abstracts)

Case series of Carcinoid heart presentation with Ovarian neuroendocrine tumour in a tertiary Centre

Nihad Mohamed 1 , Aisha Elamin 1 , Abdul Hameed 1 , L O’Toole 1 , Ziad Hussein 1 & Alia Munir 1

1Sheffield Teaching Hospital, Sheffield, United Kingdom

Background: Carcinoid heart disease (CHD) is a rare carcinoid syndrome (CS) manifestation, often linked to liver metastasis releasing vasoactive amines. CHD can also result from ovarian neuroendocrine tumours (NETs), an uncommon association.

Cases Presentations: We reviewed three female patients at our NET centre, averaging 63years of age (59-67years). They all had primary ovarian NETs causing CS and CHD.

Discussion: In all patients, investigations identified a diagnosis of CS and CHD secondary to primary ovarian NETs, evident in Tables 1&2. Table2 showed a shared pattern of dilated right ventricles and severe Pulmonary and Tricuspid valves regurgitations, emphasising the cardiac burden. Treatment encompassed both valves replacements alongside ovarian tumour removal, with receiving preoperative somatostatin analogues.One initially declined cardiac surgery but later accepted. Postoperative results uniformly demonstrated disease remission clinically, biochemically and radiologically, reflecting successful tumour resection and cardiac intervention.

Table 1
Case1 CgA: 24nmol/L 5HIAA: 857umol/L BNP: 565ng/LCgA: 6nmol/L 5HIAA: 17umol/L
Case2CgA: 2504pmol/L 5HIAA: 604umol/L BNP: 1615ng/LCgA: 27pmol/L 5HIAA: awaiting
Case3CgA: 39.7nmol/L 5HIAA: 536umol/L BNP: 477ng/LCgA: 17.5nmol/L 5HIAA: 150umol/L
Table 2
preoperative postoperative
Case1ECHO: EDD 50mm Impaired RV Awaiting
Case2MRI: RVEDV 240ml RVEF 63%Normal RV
Case3ECHO: RVEDarea 14.8cm2/m2 EDV 36.7mlRVEF 56+/-6%

Conclusion: Tumour excision and cardiac interventions provide optimistic possibilities for curing CS and CHD linked to primary ovarian NETs. Early diagnosis and multidisciplinary involvement improve clinical outcomes.

References: 1. Preda VA, Chitoni M, Talbot D, et al Primary Ovarian Carcinoid: Extensive Clinical Experience With an Underrecognized Uncommon Entity International Journal of Gynecologic Cancer 2018;28:466-47. 2. Mansour S, Anaka MR, Al-Agha R. A Case of Primary Insular Ovarian Carcinoid Tumor with Hyperandrogenism and Carcinoid Heart Disease. Am J Case Rep. 2022 Oct 1;23:e937403. doi: 10.12659/AJCR.937403. PMID: 36181247; PMCID: PMC9536143. 3. Simões-Pereira J, Wang LM, Kardos A, Grossman A. Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour. Acta Med Port. 2017 May 31;30(5):421-425. doi: 10.20344/amp.7713. Epub 2017 May 31. PMID: 28865508.

Article tools

My recent searches

No recent searches.